Hsu JY, Sikora MJ. CRISPR Fish Reel in Novel Roles for Estrogen Receptors in Reproduction. Endocrinology. 2017 07 01; 158(7):2082-2083.
CRISPR Fish Reel in Novel Roles for Estrogen Receptors in Reproduction.
Williams JS, Hsu JY, Rossi CC, Artinger KB
Williams JS, Hsu JY, Rossi CC, Artinger KB. Requirement of zebrafish pcdh10a and pcdh10b in melanocyte precursor migration. Dev Biol. 2018 12 01; 444 Suppl 1:S274-S286.
Requirement of zebrafish pcdh10a and pcdh10b in melanocyte precursor migration.
University of Colorado Denver - Anschutz Medical Campus
Zhou H, Blevins MA, Hsu JY, Kong D, Galbraith MD, Goodspeed A, Culp-Hill R, Oliphant MUJ, Ramirez D, Zhang L, Trinidad-Pineiro J, Mathews Griner L, King R, Barnaeva E, Hu X, Southall NT, Ferrer M, Gustafson DL, Regan DP, D'Alessandro A, Costello JC, Patnaik S, Marugan J, Zhao R, Ford HL
Zhou H, Blevins MA, Hsu JY, Kong D, Galbraith MD, Goodspeed A, Culp-Hill R, Oliphant MUJ, Ramirez D, Zhang L, Trinidad-Pineiro J, Mathews Griner L, King R, Barnaeva E, Hu X, Southall NT, Ferrer M, Gustafson DL, Regan DP, D'Alessandro A, Costello JC, Patnaik S, Marugan J, Zhao R, Ford HL. Identification of a Small-Molecule Inhibitor That Disrupts the SIX1/EYA2 Complex, EMT, and Metastasis. Cancer Res. 2020 06 15; 80(12):2689-2702.
Identification of a Small-Molecule Inhibitor That Disrupts the SIX1/EYA2 Complex, EMT, and Metastasis.
Iwanaga R, Truong BT, Hsu JY, Lambert KA, Vyas R, Orlicky D, Shellman YG, Tan AC, Ceol C, Artinger KB
Iwanaga R, Truong BT, Hsu JY, Lambert KA, Vyas R, Orlicky D, Shellman YG, Tan AC, Ceol C, Artinger KB. Loss of prdm1a accelerates melanoma onset and progression. Mol Carcinog. 2020 09; 59(9):1052-1063.
Loss of prdm1a accelerates melanoma onset and progression.
Hsu JY, Major JL, Riching AS, Sen R, Pires da Silva J, Bagchi RA
Biochemistry and cell biology = Biochimie et biologie cellulaire
Hsu JY, Major JL, Riching AS, Sen R, Pires da Silva J, Bagchi RA. Beyond the genome: challenges and potential for epigenetics-driven therapeutic approaches in pulmonary arterial hypertension. Biochem Cell Biol. 2020 12; 98(6):631-646.
Beyond the genome: challenges and potential for epigenetics-driven therapeutic approaches in pulmonary arterial hypertension.
Kong D, Zhou H, Neelakantan D, Hughes CJ, Hsu JY, Srinivasan RR, Lewis MT, Ford HL
Kong D, Zhou H, Neelakantan D, Hughes CJ, Hsu JY, Srinivasan RR, Lewis MT, Ford HL. VEGF-C mediates tumor growth and metastasis through promoting EMT-epithelial breast cancer cell crosstalk. Oncogene. 2021 02; 40(5):964-979.
VEGF-C mediates tumor growth and metastasis through promoting EMT-epithelial breast cancer cell crosstalk.
Hsu JY, Danis EP, Nance S, O'Brien JH, Gustafson AL, Wessells VM, Goodspeed AE, Talbot JC, Amacher SL, Jedlicka P, Black JC, Costello JC, Durbin AD, Artinger KB, Ford HL
Hsu JY, Danis EP, Nance S, O'Brien JH, Gustafson AL, Wessells VM, Goodspeed AE, Talbot JC, Amacher SL, Jedlicka P, Black JC, Costello JC, Durbin AD, Artinger KB, Ford HL. SIX1 reprograms myogenic transcription factors to maintain the rhabdomyosarcoma undifferentiated state. Cell Rep. 2022 02 01; 38(5):110323.
SIX1 reprograms myogenic transcription factors to maintain the rhabdomyosarcoma undifferentiated state.
Hughes CJ, Fields KM, Danis EP, Hsu JY, Neelakantan D, Vincent MY, Gustafson AL, Oliphant MJ, Sreekanth V, Zaberezhnyy V, Costello JC, Jedlicka P, Ford HL
Hughes CJ, Fields KM, Danis EP, Hsu JY, Neelakantan D, Vincent MY, Gustafson AL, Oliphant MJ, Sreekanth V, Zaberezhnyy V, Costello JC, Jedlicka P, Ford HL. SIX1 and EWS/FLI1 co-regulate an anti-metastatic gene network in Ewing Sarcoma. Nat Commun. 2023 07 19; 14(1):4357.
SIX1 and EWS/FLI1 co-regulate an anti-metastatic gene network in Ewing Sarcoma.
Wolin AR, Vincent MY, Hotz T, Purdy SC, Rosenbaum SR, Hughes CJ, Hsu JY, Oliphant MUJ, Armstrong B, Wessells V, Varella-Garcia M, Galbraith MD, Pierce A, Wang D, Venkataraman S, Danis E, Veo B, Serkova N, Espinosa JM, Gustafson DL, Vibhakar R, Ford HL
Wolin AR, Vincent MY, Hotz T, Purdy SC, Rosenbaum SR, Hughes CJ, Hsu JY, Oliphant MUJ, Armstrong B, Wessells V, Varella-Garcia M, Galbraith MD, Pierce A, Wang D, Venkataraman S, Danis E, Veo B, Serkova N, Espinosa JM, Gustafson DL, Vibhakar R, Ford HL. EYA2 tyrosine phosphatase inhibition reduces MYC and prevents medulloblastoma progression. Neuro Oncol. 2023 12 08; 25(12):2287-2301.
EYA2 tyrosine phosphatase inhibition reduces MYC and prevents medulloblastoma progression.
Hooper RC, Hsu J, Duncan A, Bensenhaver JM, Newman LA, Kidwell KM, Chung KC, Momoh AO
Hooper RC, Hsu J, Duncan A, Bensenhaver JM, Newman LA, Kidwell KM, Chung KC, Momoh AO. Breast Cancer Knowledge and Decisions Made for Contralateral Prophylactic Mastectomy: A Survey of Surgeons and Women in the General Population. Plast Reconstr Surg. 2019 05; 143(5):936e-945e.
Breast Cancer Knowledge and Decisions Made for Contralateral Prophylactic Mastectomy: A Survey of Surgeons and Women in the General Population.
Advances in neonatal care : official journal of the National Association of Neonatal Nurses
Hsu JY, Shuman CJ, Vance AJ. Parent Satisfaction With Neonatal Care: A Secondary Analysis. Adv Neonatal Care. 2025 Jun 01; 25(3):250-258.
Parent Satisfaction With Neonatal Care: A Secondary Analysis.
Hsu J, Morgan M, Veliz P, Shuman C. Unit Leadership and Climates for Evidence-Based Practice Implementation in Maternal-Infant Health Units: A Cross-Sectional Descriptive Study. J Adv Nurs. 2025 Nov; 81(11):7514-7524.
Unit Leadership and Climates for Evidence-Based Practice Implementation in Maternal-Infant Health Units: A Cross-Sectional Descriptive Study.
Vance AJ, Benjamin A, Hsu J, Berry JG. Care Coordination Programs for Infants With Complex Conditions: A Systematic Review. Pediatrics. 2023 Jul 01; 152(1).
Care Coordination Programs for Infants With Complex Conditions: A Systematic Review.
Kaur MN, Rae C, Morrison SD, Laungani A, Brassard P, Mullender MG, van de Grift TC, Young-Afat DA, Sørensen JA, Poulsen L, Cornacchi SD, Graesser JG, Igbokwe MM, Satterwhite T, Pang JH, Akhavan AA, Hu A, Johnson N, Cano SJ, Savard K, Mundinger GS, Capitán-Cañadas F, Simon D, Capitán L, Coon D, Brydges HT, Bluebond-Langner R, Rodriguez ED, Zhao LC, Armstrong KA, Dean NR, Crittenden TA, Cannell ZA, Lane M, Haley CA, Hsu J, Dy GW, Peters BR, Berli JU, Milano CE, Lava CX, Fan KL, Del Corral GA, Kaoutzanis C, Kalia N, Higuchi T, Ganor O, Subedi S, Douglass LM, Hamidian Jahromi A, Hosseini HC, Ihnat J, Parikh N, Hu K, Alperovich M, Ray EC, Aref Y, Hassan BA, Liang F, Mundy L, Chen ML, Pusic AL, Klassen AF
Kaur MN, Rae C, Morrison SD, Laungani A, Brassard P, Mullender MG, van de Grift TC, Young-Afat DA, Sørensen JA, Poulsen L, Cornacchi SD, Graesser JG, Igbokwe MM, Satterwhite T, Pang JH, Akhavan AA, Hu A, Johnson N, Cano SJ, Savard K, Mundinger GS, Capitán-Cañadas F, Simon D, Capitán L, Coon D, Brydges HT, Bluebond-Langner R, Rodriguez ED, Zhao LC, Armstrong KA, Dean NR, Crittenden TA, Cannell ZA, Lane M, Haley CA, Hsu J, Dy GW, Peters BR, Berli JU, Milano CE, Lava CX, Fan KL, Del Corral GA, Kaoutzanis C, Kalia N, Higuchi T, Ganor O, Subedi S, Douglass LM, Hamidian Jahromi A, Hosseini HC, Ihnat J, Parikh N, Hu K, Alperovich M, Ray EC, Aref Y, Hassan BA, Liang F, Mundy L, Chen ML, Pusic AL, Klassen AF. Development and Assessment of a Patient-Reported Outcome Instrument for Gender-Affirming Care. JAMA Netw Open. 2025 04 01; 8(4):e254708.
Development and Assessment of a Patient-Reported Outcome Instrument for Gender-Affirming Care.